These observations suggest that the observed tumor growth inhibition is likely due to a direct inhibition of cell-to-cell attachment mediated by PVRL4-PVRL1 binding, and not due to an Fc receptor-mediated immune response. The gene discussed is NECTIN4; the disease is neoplasm.